HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

GDRX

GoodRx Holdings, Inc. (NASDAQ)

Healthcare — Health Information Services

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Hold 2.5 / 5 13 analysts
$3.06
+$0.18 (+6.25%)
Target: $3.18 (3.9%)
Sign in to add GDRX to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.04B
P/E Ratio (TTM)51.00
Forward P/E8.54
EPS (TTM)$0.06
Dividend Yield-
Profit Margin2.61%
Revenue Growth-4.40%
ROE3.22%
Debt/Equity87.04
Recommendation Hold 2.5
Analyst Target$3.18
Analysts13
Indexes NASDAQ

Technical Indicators

RSI (14)73.6
Beta1.62
SMA 20-
SMA 40-
52-Week High$5.81
52-Week Low$1.77
50-Day Avg$2.65
200-Day Avg$2.82
Avg Volume$1.54M
Volume$2.07M

Performance Analysis

NEUTRAL

GDRX presents a mixed picture with both positive and negative indicators.

~ Trading at 32% of its 52-week range.
- RSI at 73.6 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 51.0 is elevated — the market expects high growth or it may be overvalued.
- Revenue declined 4.4% year-over-year.
~ Wall Street consensus is "Hold" from 13 analysts.
+ Average analyst target of $3.18 implies 3.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:11 UTC

Back to Screener Export Report